Lead Product(s) : Exosome-based Therapy
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Discovery Platform
Sponsor : Inteligex
Deal Size : Undisclosed
Deal Type : Collaboration
NurExone and Inteligex Begin Research On Chronic Spinal Cord Injury
Details : The collaboration aims to combine Inteligex’s two decades of cell therapy expertise with NurExone’s exosome platform to treat chronic spinal cord injuries.
Brand Name : Undisclosed
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
January 17, 2024
Lead Product(s) : Exosome-based Therapy
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Discovery Platform
Sponsor : Inteligex
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?